首页 > 市场调查报告书 > 製药

动物用医药

市场调查报告书

商品编码

1452738

全球马保健品市场规模、份额、成长分析、按产品类型、按适应症划分 - 产业预测 (2024-2031)

Global Equine Healthcare Market Size, Share, Growth Analysis, By Product Type(Vaccines, Pharmaceuticals), By Indication(Musculoskeletal Disorders, Internal Medicine) - Industry Forecast 2024-2031

出版日期: 2024年03月08日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球马保健市场规模为28.7亿美元，从2023年的33.6亿美元成长到2031年的117亿美元，预测期内（2024-2031年）预计复合年增长率为16.9%。

多种因素促进了马医疗保健行业的显着成长。其中包括对赛马和体育行业的投资、马疾病的流行以及行业相关人员对马医疗保健服务日益增长的需求。委内瑞拉马脑脊髓炎、狂犬病、西尼罗热病和马流感等马疾病在全球蔓延，需要有效的预防和治疗方案（OIE于2021年发布）。

马业受到 COVID-19 大流行的严重影响。政府的限制措施暂时关闭了一些设施，并使营运商陷入财务困境。

马兽医已经习惯了基于远端医疗的程序，因此当失业率上升时，对马健康的担忧就凸显出来。不过，这些影响是暂时的，市场正稳定復苏。

由于认识到动物保健对人类和动物都很重要，公众对动物保健的认识将在预测期内提高。为了阻止疾病从动物传播给人类，政府和私人组织正在对动物保健基础设施进行重大投资。例如，美国农业部在动物营养和健康方面花费了 30 亿美元。

马匹对于越野骑行和骑马课程等休閒来说是必不可少的，而马匹的维护、供应和活动的成本很高。这些努力显着增加了就业机会和经济价值。拥有最先进设备以及马匹医疗和诊断用品的兽医医院的存在进一步支持了市场扩张。利物浦大学菲利普·莱弗休姆马科医院等知名机构提供的最新诊断工具正在改善马匹护理和治疗选择。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2021年）
主要市场参与者所采取的策略
关键成功策略
近期市集活动
主要企业市场占有率（2021年）

主要企业简介

Zoetis Inc.
Merck Animal Health
Boehringer Ingelheim International GmbH
Elanco Animal Health
Bayer AG
Ceva Sante Animale
Virbac
Dechra Pharmaceuticals PLC
IDEXX Laboratories, Inc.
Vetoquinol SA
Norbrook Laboratories Limited
EQUINE PRODUCTS UK LTD
KRKA
HIPRA
Luitpold Pharmaceuticals, Inc.

简介目录

Product Code: SQMIG35G2223

The Global Equine Healthcare Market size was valued at USD 2.87 billion in 2022 and is poised to grow from USD 3.36 billion in 2023 to USD 11.70 billion by 2031, growing at a CAGR of 16.9% in the forecast period (2024-2031).

A number of causes are contributing to the significant growth of the equine healthcare sector. These include investments in the equine racing and sports sector, an increase in the prevalence of equine diseases, and the growing demand for equine healthcare services from industry stakeholders. Effective prevention and treatment options are in high demand due to the global expansion of horse diseases such Venezuelan equine encephalomyelitis, rabies, West Nile fever, and equine influenza, as stated by the OIE in 2021.

The equine sector was significantly impacted by the COVID-19 pandemic. Government regulations caused several facilities to close temporarily, which put operators in a difficult financial situation.

Equine veterinarians were accustomed to telehealth-based procedures, and when unemployment rates rose, worries about the wellbeing of the horses surfaced. These effects, meanwhile, were only temporary, as the market steadily recovered.

Increased public awareness of animal healthcare throughout the forecast period will be fueled by knowledge of its significance for both people and animals. To stop diseases from spreading from animals to people, governments and private organizations are making large investments in the infrastructure of animal healthcare. The U.S. Department of Agriculture, for instance, has spent $3 billion on the nutrition and health of animals.

Horses are essential to leisure pursuits such as trail rides and riding classes, which increases the cost of horse maintenance, supplies, and activity fees. These endeavors significantly enhance the generation of jobs and economic value. The availability of veterinary institutions with state-of-the-art equipment and medical and diagnostic supplies for horses drives market expansion even more. Modern diagnostic tools are provided by renowned establishments like the Philip Leverhulme Equine Hospital at the University of Liverpool, improving equine care and therapy alternatives.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Equine Healthcare Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Equine Healthcare Market Segmental Analysis

There are four main segments in the global equine healthcare market: Product Type, Indication, Distribution Channel, and Region. The market is divided into the following segments based on product type: software & services, pharmaceuticals, medicinal feed additives, vaccines, and others. The market is divided into segments based on indication, including tetanus, internal medicine, equine herpes virus, equine encephalomyelitis, equine influenza, west nile virus, and musculoskeletal disorders. The market is divided into three segments based on distribution: e-commerce, veterinary hospitals & clinics, and others. The market is divided into four regions: North America, Europe, Asia-Pacific, and Latin America.

Drivers of the Global Equine Healthcare Market

The need for cutting-edge healthcare solutions is being driven by the growing knowledge of and concern for the health and welfare of horses, particularly in high-performance industries like racing, sports, and leisure.

Restraints in the Global Equine Healthcare Market

The timely and effective delivery of healthcare may be impacted in some places by a lack of specialized horse veterinarians and medical facilities.

Market Trends of the Global Equine Healthcare Market

Personalized Healthcare Solutions: A trend toward more individualized treatment regimens and approaches is now observed in the horse healthcare industry. More and more, specialized treatment plans, genetic testing, and advanced diagnostics are being used to address the unique health needs of individual horses.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Equine Healthcare Market by Product Type

Market Overview
Vaccines
Pharmaceuticals
Medicinal Feed Additives
Diagnostics
Software & Services
and Others

Global Equine Healthcare Market by Indication

Market Overview
Musculoskeletal Disorders
Internal Medicine
Equine Herpes Virus
Equine Encephalomyelitis
Equine Influenza
West Nile Virus
Tetanus
and Others.

Global Equine Healthcare Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Zoetis Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck Animal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim International GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elanco Animal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ceva Sante Animale
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Virbac
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dechra Pharmaceuticals PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IDEXX Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vetoquinol S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Norbrook Laboratories Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EQUINE PRODUCTS UK LTD
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
KRKA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HIPRA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luitpold Pharmaceuticals, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments